Search Results - "Mahendranath, Kurugodu Mathada"
-
1
Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real‐world clinical experience from India
Published in International journal of rheumatic diseases (01-02-2019)“…Aim Tuberculosis (TB) is one of the major adverse events of concern associated with the use of biologics for managing autoimmune inflammatory rheumatic…”
Get full text
Journal Article -
2
Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India
Published in Rheumatology international (01-03-2019)“…Biologic disease-modifying anti-rheumatic drugs (bDMARD) have transformed the treatment paradigm of chronic autoimmune rheumatic diseases (ARDs), but they are…”
Get full text
Journal Article -
3
Influence of disease duration and socioeconomic factors on the prevalence of infection and hospitalization in rheumatoid arthritis: KRAC study
Published in International journal of rheumatic diseases (01-07-2019)“…Aim The use of healthcare resources by rheumatoid arthritis (RA) patients can be related to the presence of disease, comorbid conditions, use of steroids, and…”
Get full text
Journal Article -
4
Reduced incidence of extra‐articular manifestations of RA through effective disease control: Karnataka Rheumatoid Arthritis Comorbidity (KRAC) study
Published in International journal of rheumatic diseases (01-11-2017)“…Aim To estimate the prevalence of extra‐articular manifestations (EAM) in rheumatoid arthritis (RA) patients and the impact of demographic, clinical and…”
Get full text
Journal Article